The goal of current examine was to re-evaluate the impacts of elevated Fe(III) stress on anaerobic ammonium oxidation (anammox) process. The outcomes indicated that long-term low focus Fe(III) (5 and 10 mg/L) publicity considerably improved the nitrogen elimination effectivity of anammox process, whereas excessive focus Fe(III) (50 and 100 mg/L) considerably deteriorated the reactor efficiency.
Batch assays confirmed that the precise anammox exercise, heme c content material and hydrazine dehydrogenase exercise have been considerably elevated and decreased below low and excessive focus Fe(III) publicity, respectively, indicating an enhancement and inhibition of anammox exercise. Moreover, the presence of excessive focus Fe(III) considerably shifted the anammox community construction.
Ca. Brocadia was the predominant anammox genus, whose abundance decreased from 14.26% to 8.13% as Fe(III) focus elevated from 0 to 100 mg/L. In comparability, the abundance of denitrifiers progressively elevated from 3.70% to 6.68% with growing Fe(III) focus. These recommended that completely different functional micro organism differed of their responses to Fe(III) stress.
Furthermore, long-term Fe(III) publicity considerably up-regulated the abundances of genes related to nitrogen metabolism and Fe(III) discount. Overall, the obtained findings are anticipated to advances our understanding of the responses of anammox process to elevated Fe(III) stress.
Schizophrenia is a fancy mind dysfunction with genetic and environmental elements contributing to its etiology. Complement C4 genes are schizophrenia susceptibility loci and are activated in response to infections and intestine microbiome imbalances. We hypothesize that C4 genetic susceptibility predisposes people to neuropathological results from pathogen exposures or a microbiome in dysbiosis. In 214 people with schizophrenia and 123 non-psychiatric controls, we examined C4 gene copy quantity and haplotype teams for associations with schizophrenia and microbial plasma biomarkers.
C4A copy quantity and haplotypes containing HERV-Okay insertions (C4A-long; C4AL-C4AL) conferred elevated odds ratios for schizophrenia diagnoses (OR 1.58-2.56, p < 0.0001), whereas C4B-short (C4BS) haplogroups conferred decreased odds. In schizophrenia solely, LBP and CMV IgG ranges have been inversely correlated with C4A and C4S copy numbers, respectively.
C4 haplogroups have been related to altered scores of cognitive functioning in each circumstances and controls and with psychiatric symptom scores in schizophrenia. Our findings hyperlink complement C4 genes with a susceptibility to infections and a dysbiotic microbiome in schizophrenia. These outcomes assist immune system mechanisms by which gene-environmental interactions could also be operative in schizophrenia.
A biofoundry workflow for the identification of genetic determinants of microbial progress inhibition
Biofoundries combine high-throughput software program and {hardware} platforms with artificial biology approaches to allow the design, execution and analyses of large-scale experiments. The distinctive and highly effective mixture of laboratory infrastructure and experience in molecular biology and automation programming, present versatile assets for a variety of workflows and analysis areas.
Here, we reveal the applicability of biofoundries to molecular microbiology, describing the event and utility of automated workflows to establish the genetic foundation of progress inhibition of the plant pathogen Streptomyces scabies by a Pseudomonas pressure remoted from a potato area. Combining transposon mutagenesis with automated high-throughput antagonistic assays, the workflow accelerated the screening of 2880 mutants to correlate progress inhibition with a biosynthetic gene cluster inside 2 weeks.
Several present applied sciences allow brief genomic alterations together with producing indels and brief nucleotide variants, nonetheless, engineering extra important genomic adjustments is tougher due to diminished effectivity and precision. Here, we developed RecT Editor by way of Designer-Cas9-Initiated Targeting (REDIT), which leverages phage single-stranded DNA-annealing proteins (SSAP) RecT for mammalian genome engineering.
Relative to Cas9-mediated homology-directed restore (HDR), REDIT yielded up to a 5-fold enhance of effectivity to insert kilobase-scale exogenous sequences at outlined genomic areas. We validated our REDIT strategy utilizing completely different codecs and lengths of knock-in templates.
We additional demonstrated that REDIT instruments utilizing Cas9 nickase have environment friendly gene-editing actions and diminished off-target errors, measured utilizing a mix of focused sequencing, genome-wide indel, and insertion mapping assays. Our experiments inhibiting restore enzyme actions recommended that REDIT has the potential to overcome limitations of endogenous DNA restore steps. Finally, our REDIT methodology is relevant throughout cell varieties together with human stem cells, and is generalizable to completely different Cas9 enzymes.
The destiny and long-term poisonous results of NiO nanoparticles at environmental focus in constructed wetland: Enzyme exercise, microbial property, metabolic pathway and functional genes
Although the potential threats of metallic oxide nanoparticles (MNPs) to constructed wetland (CW) have been broadly reported, restricted info is accessible relating to the long-term affect of nickel oxide nanoparticles (NiO NPs) on CWs on the environmentally related concentrations. Here, we comprehensively elucidated the responses within the therapy efficiency, enzyme actions, microbial properties, metabolic pathways and functional genes of CWs to persistent publicity of NiO NPs (0.1 and 1 mg/L) for 120 days, with a quantitative evaluation on the destiny and migration of NiO NPs inside CWs. Nitrogen elimination evidently declined below the long-term publicity to NiO NPs. Besides, NiO NPs induced a deterioration in phosphorus elimination, however step by step restored over time.
Recombinant Hepatitis C virus Genome polyprotein,partial |
AP72393 |
SAB |
each |
Ask for price |
|
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
AP73727 |
SAB |
each |
Ask for price |
|
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
AP73728 |
SAB |
each |
Ask for price |
|
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
CSB-MP333180HFD |
Cusabio |
4998 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
CSB-YP530838HVQ(A3) |
Cusabio |
6465 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
CSB-YP530838HVQ(A4) |
Cusabio |
6466 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
CSB-EP333180HFD |
Cusabio |
3004 mg |
Ask for price |
Hepatitis C Genome polyprotein |
1-CSB-RP184674Ba |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis C Genome polyprotein expressed in E.coli |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein(E1),partial |
AP70969 |
SAB |
1mg |
EUR 2826 |
|
Recombinant Hepatitis C Genome polyprotein |
CSB-RP184674Ba |
Cusabio |
5430 mg |
Ask for price |
Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
1-CSB-EP327230HGE |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1(ORF1),partial expressed in E.coli |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
AP71039 |
SAB |
1mg |
EUR 2826 |
|
Recombinant Hepatitis C Virus polyprotein, His, E.coli-1mg |
QP8939-ec-1mg |
EnQuireBio |
1mg |
EUR 2763.6 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-10ug |
QP8939-ec-10ug |
EnQuireBio |
10ug |
EUR 391.2 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-50ug |
QP8939-ec-50ug |
EnQuireBio |
50ug |
EUR 522 |
Yellow fever virus Genome polyprotein |
1-CSB-EP365905YAC1 |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-100ug |
QP8939-ec-100ug |
EnQuireBio |
100ug |
EUR 848.4 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-200ug |
QP8939-ec-200ug |
EnQuireBio |
200ug |
EUR 1338 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-500ug |
QP8939-ec-500ug |
EnQuireBio |
500ug |
EUR 1816.8 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-1mg |
QP6996-1mg |
EnQuireBio |
1mg |
EUR 3037.2 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1), partial |
CSB-EP327230HGE |
Cusabio |
2937 mg |
Ask for price |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-1mg |
QP9739-ye-1mg |
EnQuireBio |
1mg |
EUR 3296.4 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-10ug |
QP6996-10ug |
EnQuireBio |
10ug |
EUR 426 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-200ug |
QP6996-200ug |
EnQuireBio |
200ug |
EUR 1468.8 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-20ug |
QP6996-20ug |
EnQuireBio |
20ug |
EUR 523.2 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-500ug |
QP6996-500ug |
EnQuireBio |
500ug |
EUR 1936.8 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-100ug |
QP9739-ye-100ug |
EnQuireBio |
100ug |
EUR 945.6 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-10ug |
QP9739-ye-10ug |
EnQuireBio |
10ug |
EUR 434.4 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-200ug |
QP9739-ye-200ug |
EnQuireBio |
200ug |
EUR 1512 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-500ug |
QP9739-ye-500ug |
EnQuireBio |
500ug |
EUR 2164.8 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-50ug |
QP9739-ye-50ug |
EnQuireBio |
50ug |
EUR 576 |
Japanese encephalitis virus Genome polyprotein |
1-CSB-EP189574Ba |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Japanese encephalitis virus Genome polyprotein,partial expressed in E.coli |
Recombinant Zika virus Genome polyprotein, partial |
CSB-EP3643GOZ3 |
Cusabio |
7769 mg |
Ask for price |
Genome Polyprotein Antibody |
20-abx109417 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody |
1-CSB-PA18549A0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
1-CSB-PA714772LA01HYH |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
1-CSB-PA333180LA01HFD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
1-CSB-PA362073LA01HQD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
20-abx300967 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody |
CSB-PA4643XA11GSV |
Cusabio |
100ul / 50ul |
EUR 299 |
|
Description: Genome polyprotein |
Genome polyprotein Antibody |
CSB-PA4644XA11GSW |
Cusabio |
100ul / 50ul |
EUR 299 |
|
Description: Genome polyprotein |
Recombinant West Nile virus Genome polyprotein, partial |
CSB-EP356974WAF2 |
Cusabio |
9323 mg |
Ask for price |
Genome polyprotein Antibody (HRP) |
20-abx109095 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody (HRP) |
20-abx300968 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Recombinant Yellow fever virus Genome polyprotein,partial |
RPC22821-100ug |
Biomatik Corporation |
100ug |
EUR 721.6 |
Recombinant Yellow fever virus Genome polyprotein,partial |
RPC22821-1mg |
Biomatik Corporation |
1mg |
EUR 2884.7 |
Recombinant Yellow fever virus Genome polyprotein,partial |
RPC22821-20ug |
Biomatik Corporation |
20ug |
EUR 448.1 |
Recombinant Yellow fever virus Genome polyprotein,partial |
AP77947 |
SAB |
1mg |
EUR 2826 |
|
Recombinant Yellow fever virus Genome polyprotein, partial |
CSB-EP365905YAC1 |
Cusabio |
3485 mg |
Ask for price |
Genome polyprotein Antibody (FITC) |
20-abx107678 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody (FITC) |
20-abx300969 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody (Biotin) |
20-abx106264 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome Polyprotein Antibody (Biotin) |
20-abx105887 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody (Biotin) |
20-abx300970 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Recombinant Japanese encephalitis virus Genome polyprotein, partial |
CSB-EP189574Ba |
Cusabio |
2537 mg |
Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein,partial |
RPC28130-100ug |
Biomatik Corporation |
100ug |
EUR 1544.5 |
Recombinant Bovine viral diarrhea virus Genome polyprotein,partial |
RPC28130-20ug |
Biomatik Corporation |
20ug |
EUR 580.8 |
Recombinant Bovine viral diarrhea virus Genome polyprotein, partial |
CSB-BP312464BKX1 |
Cusabio |
139 mg |
Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein, partial |
CSB-EP312464BKX1 |
Cusabio |
2704 mg |
Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein , partial |
CSB-YP312464BKX1 |
Cusabio |
6140 mg |
Ask for price |
Recombinant Dengue virus type 2 Genome polyprotein, partial |
CSB-YP530838DCF |
Cusabio |
7267 mg |
Ask for price |
Recombinant Classical swine fever virus Genome polyprotein, partial |
CSB-BP4334GLU |
Cusabio |
10139 mg |
Ask for price |
Recombinant Classical swine fever virus Genome polyprotein, partial |
CSB-EP4953GLU |
Cusabio |
11663 mg |
Ask for price |
Recombinant Classical swine fever virus Genome polyprotein, partial |
CSB-YP4953GLU |
Cusabio |
12085 mg |
Ask for price |
Recombinant St. louis encephalitis virus Genome polyprotein, partial |
CSB-EP357746SKT |
Cusabio |
9322 mg |
Ask for price |
Rhinovirus A serotype 89 Genome polyprotein Antibody |
20-abx109372 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome Polyprotein Polyclonal Antibody |
A68253 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Genome Polyprotein Polyclonal Antibody |
A68254 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Genome Polyprotein Polyclonal Antibody |
A56743 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Genome Polyprotein Polyclonal Antibody |
A56130 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Enterovirus 71 Genome polyprotein Antibody |
20-abx109758 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Genome polyprotein Antibody, HRP conjugated |
1-CSB-PA18549B0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
1-CSB-PA714772LB01HYH |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
1-CSB-PA333180LB01HFD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
1-CSB-PA362073LB01HQD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is HRP conjugated. Tested in the following application: ELISA |
Recombinant Tick-borne encephalitis virus Genome polyprotein, partial |
CSB-EP3056GKR |
Cusabio |
2646 mg |
Ask for price |
Genome polyprotein Antibody, FITC conjugated |
1-CSB-PA18549C0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
1-CSB-PA714772LC01HYH |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
1-CSB-PA333180LC01HFD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
1-CSB-PA362073LC01HQD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
1-CSB-PA18549D0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
1-CSB-PA714772LD01HYH |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
1-CSB-PA333180LD01HFD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
1-CSB-PA362073LD01HQD |
Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome Polyprotein (HCV-Core) Antibody |
33487-05111 |
AssayPro |
150 ug |
EUR 313.2 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
20-abx108723 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
20-abx107303 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Recombinant Dengue virus type 2 Genome polyprotein (Q1642N), partial |
CSB-EP3044GLD(M) |
Cusabio |
11736 mg |
Ask for price |
Enterovirus 71 Genome polyprotein Antibody (HRP) |
20-abx108220 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Enterovirus 71 Genome polyprotein Antibody (FITC) |
20-abx106801 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
20-abx105382 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Recombinant Dengue virus 2 Genome polyprotein (T2493G,G2494S,I2762T), partial |
CSB-EP2239GLD(M) |
Cusabio |
11735 mg |
Ask for price |
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
A68252 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
A68255 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
A56744 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
A56131 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
A68251 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
A68256 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
A56745 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
A56132 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
A68250 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
A68257 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
A56746 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
A56133 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Recombinant Tick-borne encephalitis virus European subtype Genome polyprotein, partial |
CSB-EP318509TEM |
Cusabio |
11863 mg |
Ask for price |
Genome Polyprotein (HCV-Core) Antibody (Biotin Conjugate) |
33487-05121 |
AssayPro |
150 ug |
EUR 442.8 |
Recombinant Tick-borne encephalitis virus Far Eastern subtype Genome polyprotein, partial |
CSB-EP357187TEN |
Cusabio |
11862 mg |
Ask for price |
Recombinant Tick-borne encephalitis virus Far Eastern subtype Genome polyprotein, partial |
CSB-EP357187TENa0 |
Cusabio |
11843 mg |
Ask for price |
Recombinant Tick-borne encephalitis virus Far Eastern subtype Genome polyprotein, partial |
CSB-EP357187TENc7 |
Cusabio |
11839 mg |
Ask for price |
Human rhinovirus A serotype 89 Genome polyprotein |
1-CSB-EP362073HQD |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
Human rhinovirus A serotype 89 Genome polyprotein |
1-CSB-EP362073HQDb0 |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
Human rhinovirus A serotype 89 Genome polyprotein |
1-CSB-YP362073HQD |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in Yeast |
Human rhinovirus 1A Genome polyprotein |
1-CSB-YP326367HQA |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
Genome Polyprotein (HCV-Core) AssayLite Antibody (RPE Conjugate) |
33487-05151 |
AssayPro |
150 ug |
EUR 513.6 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (APC Conjugate) |
33487-05161 |
AssayPro |
150 ug |
EUR 513.6 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (FITC Conjugate) |
33487-05141 |
AssayPro |
150 ug |
EUR 513.6 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (PerCP Conjugate) |
33487-05171 |
AssayPro |
150 ug |
EUR 565.2 |
Recombinant Human parechovirus 1 Genome polyprotein |
CSB-YP734409HCAV |
Cusabio |
9748 mg |
Ask for price |
Duck Hepatitis Virus Antibody (DHV-Ab) ELISA Kit |
abx054977-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
VAng-Cr6542-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 3408 |
Description: YFV Genome polyprotein, recombinant protein. |
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
VAng-Cr6542-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2452.8 |
Description: YFV Genome polyprotein, recombinant protein. |
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
VAng-Cr6542-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1693.2 |
Description: YFV Genome polyprotein, recombinant protein. |
Recombinant JEV Genome polyprotein (aa 2528-3432) Protein |
VAng-Wyb3447-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 9926.4 |
Description: Japanese encephalitis virus (strain Jaoars982) Genome polyprotein, recombinant protein. |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-10ug |
QP7125-10ug |
EnQuireBio |
10ug |
EUR 426 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-1mg |
QP7125-1mg |
EnQuireBio |
1mg |
EUR 3037.2 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-50ug |
QP7125-50ug |
EnQuireBio |
50ug |
EUR 567.6 |
Recombinant Human parechovirus 1 Genome polyprotein, partial |
CSB-EP734409HCAV |
Cusabio |
9651 mg |
Ask for price |
Duck Hepatitis Virus (DHV) ELISA Kit |
abx054976-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Recombinant YFV Genome polyprotein (NS4A) Protein (aa 1-3412) |
VAng-Cr6545-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: YFV (isolate Uganda/A7094A4/1948) Genome polyprotein (NS4A), recombinant protein. |
Recombinant Enterovirus A71 Genome polyprotein,partial |
RPC28548-100ug |
Biomatik Corporation |
100ug |
EUR 801.9 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
RPC28548-1mg |
Biomatik Corporation |
1mg |
EUR 2885.2 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
RPC28548-20ug |
Biomatik Corporation |
20ug |
EUR 448.1 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
RPC28549-100ug |
Biomatik Corporation |
100ug |
EUR 801.9 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
RPC28549-1mg |
Biomatik Corporation |
1mg |
EUR 2885.2 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
RPC28549-20ug |
Biomatik Corporation |
20ug |
EUR 448.1 |
Recombinant Enterovirus A71 Genome polyprotein, partial |
CSB-EP3114GLA |
Cusabio |
7385 mg |
Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
CSB-EP3114GLAa2 |
Cusabio |
7384 mg |
Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
CSB-EP3114GLAe0 |
Cusabio |
7511 mg |
Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
CSB-EP3114GLAe1 |
Cusabio |
7917 mg |
Ask for price |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-100ug |
QP7125-100ug |
EnQuireBio |
100ug |
EUR 925.2 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-200ug |
QP7125-200ug |
EnQuireBio |
200ug |
EUR 1468.8 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-500ug |
QP7125-500ug |
EnQuireBio |
500ug |
EUR 1936.8 |
Recombinant Human Genome polyprotein, His, Yeast-1mg |
QP7370-ye-1mg |
EnQuireBio |
1mg |
EUR 2262 |
Recombinant Coxsackievirus B3 Genome polyprotein, partial |
CSB-EP361017CRM1 |
Cusabio |
8884 mg |
Ask for price |
Recombinant Human Genome polyprotein, His, Yeast-10ug |
QP7370-ye-10ug |
EnQuireBio |
10ug |
EUR 283.2 |
Recombinant Human Genome polyprotein, His, Yeast-50ug |
QP7370-ye-50ug |
EnQuireBio |
50ug |
EUR 358.8 |
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
VAng-Cr6541-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 5751.6 |
Description: YFV Genome polyprotein, partial, recombinant protein. |
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
VAng-Cr6541-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3657.6 |
Description: YFV Genome polyprotein, partial, recombinant protein. |
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
VAng-Cr6541-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1083.6 |
Description: YFV Genome polyprotein, partial, recombinant protein. |
Recombinant Human Genome polyprotein, His, Yeast-100ug |
QP7370-ye-100ug |
EnQuireBio |
100ug |
EUR 576 |
Recombinant Human Genome polyprotein, His, Yeast-200ug |
QP7370-ye-200ug |
EnQuireBio |
200ug |
EUR 892.8 |
Recombinant Human Genome polyprotein, His, Yeast-500ug |
QP7370-ye-500ug |
EnQuireBio |
500ug |
EUR 1447.2 |
The actions of dehydrogenase (DHA), phosphatase (PST), urease (URE), ammonia oxygenase (AMO) and nitrate reductase (NAR) have been inhibited to some extent below NiO NPs stress. Furthermore, NiO NPs publicity diminished bacterial variety, shifted microbial composition and clearly inhibited the transcription of the ammonia oxidizing and denitrifying functional genes. The outcomes of nickel mass steadiness indicated that the main elimination mechanism of NiO NPs in CWs was by means of substrate adsorption and vegetation uptake. Thus, the ecological impacts of extended NiO NPs publicity at environmental concentrations shouldn’t be uncared for.